Search

Author/Creator Boross, Peter

1. 704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models. (9th November 2020)

Authors:
Kemper, Kristel; Gielen, Ellis; Houtkamp, Mischa; Boross, Peter; Burm, Saskia; Poot, Stefanie De; Engelberts, Patrick; Goeij, Bart de; Satijn, David; Sasser, Kate; Breij, Esther
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A746
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 704 Preclinical mechanism of action and pharmacodynamic biomarker studies of DuoBody®-CD3x5T4 in vitro and in vivo in solid cancer models. (9th November 2020)

Authors:
Kemper, Kristel; Gielen, Ellis; Houtkamp, Mischa; Boross, Peter; Burm, Saskia; Poot, Stefanie De; Engelberts, Patrick; Goeij, Bart de; Satijn, David; Sasser, Kate; Breij, Esther
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8(2020)Supplement 3
Page Start:
A423
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA. Issue 1 (2nd January 2016)

Authors:
Rouwendal, Gerard JA; van der Lee, Miranda M; Meyer, Saskia; Reiding, Karli R; Schouten, Jan; de Roo, Guy; Egging, David F; Leusen, Jeanette HW; Boross, Peter; Wuhrer, Manfred; Verheijden, Gijs F; Dokter, Wim H; Timmers, Marco; Ubink, Ruud
Journal:
MAbs
Issue:
Volume 8:Issue 1(2016)
Page Start:
74
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy. Issue 1 (10th January 2022)

Authors:
Budding, Kevin; Johansen, Lill Eva; Van de Walle, Inge; Dijkxhoorn, Kim; de Zeeuw, Elisabeth; Bloemenkamp, Lauri M.; Bos, Jeroen W.; Jansen, Marc D.; Curial, Chantall A.D.; Silence, Karen; de Haard, Hans; Blanchetot, Christophe; Van de Ven, Liesbeth; Leusen, Jeanette H.W.; Pasterkamp, R. Jeroen; ...
Journal:
Neurology
Issue:
Volume 9:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy. Issue 1 (January 2022)

Authors:
Budding, Kevin; Johansen, Lill Eva; Van de Walle, Inge; Dijkxhoorn, Kim; de Zeeuw, Elisabeth; Bloemenkamp, Lauri M.; Bos, Jeroen W.; Jansen, Marc D.; Curial, Chantall A.D.; Silence, Karen; de Haard, Hans; Blanchetot, Christophe; Van de Ven, Liesbeth; Leusen, Jeanette H.W.; Pasterkamp, R. Jeroen; ...
Journal:
Neurology
Issue:
Volume 9:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Identification of a novel CD40 ligand for targeted imaging of inflammatory plaques by phage display. Issue 10 (29th July 2013)

Authors:
Yu, Haixiang; Segers, Filip; Sliedregt‐Bol, Karen; Bot, Ilze; Woltman, Andrea M.; Boross, Peter; Verbeek, Sjef; Overkleeft, Herman; van der Marel, Gijs A.; van Kooten, Cees; van Berkel, Theo J. C.; Biessen, Erik A. L.
Journal:
FASEB journal
Issue:
Volume 27:Issue 10(2013)
Page Start:
4136
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. IgA EGFR antibodies mediate tumour killing in vivo. Issue 8 (5th August 2013)

Authors:
Boross, Peter; Lohse, Stefan; Nederend, Maaike; Jansen, Johannes Hendrik Marco; van Tetering, Geert; Dechant, Michael; Peipp, Matthias; Royle, Louise; Liew, Li Phing; Boon, Louis; van Rooijen, Nico; Bleeker, Wim K.; Parren, Paul W. H. I.; van de Winkel, Jan G. J.; Valerius, Thomas; Leusen, Jeanet...
Journal:
EMBO molecular medicine
Issue:
Volume 5:Issue 8(2013:Aug.)
Page Start:
1213
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting. Issue 1 (2nd January 2016)

Authors:
Meyer, Saskia; Nederend, Maaike; Jansen, J.H. Marco; Reiding, Karli R.; Jacobino, Shamir R.; Meeldijk, Jan; Bovenschen, Niels; Wuhrer, Manfred; Valerius, Thomas; Ubink, Ruud; Boross, Peter; Rouwendal, Gerard; Leusen, Jeanette H.W.
Journal:
MAbs
Issue:
Volume 8:Issue 1(2016)
Page Start:
87
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. New insights in Type I and II CD20 antibody mechanisms‐of‐action with a panel of novel CD20 antibodies. (22nd February 2018)

Authors:
Meyer, Saskia; Evers, Mitchell; Jansen, Johannes H. M.; Buijs, Jos; Broek, Blanca; Reitsma, Stephanie E.; Moerer, Petra; Amini, Mojtaba; Kretschmer, Anna; ten Broeke, Toine; den Hartog, Marcel T.; Rijke, Mark; Klein, Christian; Valerius, Thomas; Boross, Peter; Leusen, Jeanette H. W.
Journal:
British journal of haematology
Issue:
Volume 180:Number 6(2018)
Page Start:
808
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗